Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation

Transplant Proc. 1998 May;30(3):868-70. doi: 10.1016/s0041-1345(98)00080-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • CD2 Antigens / immunology*
  • CD4-CD8 Ratio
  • Coronary Disease / pathology
  • Coronary Disease / prevention & control*
  • Cyclosporine / therapeutic use
  • Graft Rejection
  • Graft Survival
  • Heart Transplantation / immunology
  • Heart Transplantation / pathology*
  • Immunosuppressive Agents / therapeutic use
  • Postoperative Complications / prevention & control
  • Rats
  • Rats, Inbred Lew
  • Rats, Inbred Strains
  • Transplantation, Heterotopic
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • CD2 Antigens
  • Immunosuppressive Agents
  • OX-34 monoclonal antibody
  • Cyclosporine